What’s at stake as Beijing beats global peers with first approval of novel therapy
AdvertisementChina’s private sectorBusinessChina Business What’s at stake as Beijing beats global peers with first approval of novel therapy Push to…
China’s lab monkey prices hit Covid-era highs on new drug R&D demand
AdvertisementScienceChinaScience China’s lab monkey prices hit Covid-era highs on new drug R&D demand Long macaque breeding cycles and fully pre-booked…
China’s biotech surge sparks US security concerns as drug trials break records in 2025
AdvertisementChina’s private sectorBusinessChina Business China’s biotech surge sparks US security concerns as drug trials break records in 2025 Cancer treatments…
China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials
AdvertisementBiomedicine: CompaniesBusinessChina Business China’s Innovent Biologics signs US$10.5 billion Pfizer deal for 12 cancer drug trials The agreement covers eight…
China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom
AdvertisementChina’s private sectorBusinessChina Business China’s drug regulator clears wave of home-grown innovative medicines amid biotech boom Domestic firms dominate China’s…
China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS
AdvertisementChina’s private sectorBusinessChina Business China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS Company’s shares jump in Hong…